D-0699-2026 Class II Ongoing
FDA drug recall D-0699-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated The recall status is ongoing. Affected quantity: 5,555 bottles and tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2026
- Initiation Date
- Apr 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,555 bottles and tubes
Product description
Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,
Reason for recall
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Distribution pattern
Nationwide in the USA
Code information
Lots: (a) 1 oz - BL3435, Exp 11/06/26; BL3525, Exp 08/07/27. (b) 3 oz- Lots # BL3435, 11/06/26 & BL3525, 08/07/27
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0699-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026